tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market
AVBP
ArriVent BioPharma, Inc.
RESEARCH TOOLSreports

ArriVent BioPharma, Inc. (AVBP) Cash flow

78 Followers

ArriVent BioPharma, Inc. Cash Flow

AVBP's free cash flow for Q4 2025 was $-30.66M. For the 2025 fiscal year, AVBP's free cash flow was decreased by $-90.38M and operating cash flow was $-30.66M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -160.59M$ -70.21M$ -55.84M$ -43.63M$ -12.59M
Investing Cash Flow
$ -71.23M$ -192.47M$ 0.00$ 0.00$ -40.00M
Financing Cash Flow
$ 203.06M$ 186.58M$ 42.86M$ 169.72M$ 89.87M
End Cash Position
$ 45.54M$ 74.29M$ 150.39M$ 163.37M$ 37.28M
Free Cash Flow
$ -160.59M$ -70.21M$ -55.84M$ -43.63M$ -12.59M
Currency in USD

ArriVent BioPharma, Inc. Cash Flow